Esatec 20/Esatec 40

Esatec 20/Esatec 40

olmesartan

Manufacturer:

Unison

Distributor:

Unison

Marketer:

Unison
Concise Prescribing Info
Contents
Olmesartan
Indications/Uses
HTN.
Dosage/Direction for Use
HTN Adult Initially 20 mg once daily. Titrate as needed up to 40 mg once daily after 2 wk. Childn 6-16 yr weighing ≥35 kg Initially 20 mg once daily. May be increased to max 40 mg/day after 2 wk, if initial response is inadequate, <35 kg Initially 10 mg once daily. May be increased to max 20 mg/day after 2 wk, if initial response is inadequate. Elderly May consider starting at 5-10 mg once daily. Patients w/ renal impairment (CrCl <20 mL/min) Max: 20 mg/day.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Concomitant use w/ aliskiren in patients w/ DM or moderate to severe renal impairment (GFR <60 mL/min/1.73 m2).
Special Precautions
Angioedema. May develop severe, chronic diarrhea w/ significant wt loss from mth to yr after treatment initiation. Hyperkalemia may occur; risk factors include renal dysfunction, DM, concomitant use w/ K-sparing diuretics, K supplements &/or K-containing salts. Symptomatic hypotension may occur upon initiation in patients who are salt- or vol-depleted. Renal function deterioration &/or increase in serum creatinine in patients w/ low renal blood flow w/ GFR dependent on efferent arteriolar vasoconstriction by angiotensin II. Aortic/mitral stenosis; ascites; unstented unilateral/bilateral renal artery stenosis & avoid use if unstented bilateral artery stenosis occur. Pregnancy (discontinue immediately) & lactation.
Adverse Reactions
Dizziness, headache, hyperglycemia, hypertriglyceridemia, diarrhea, hematuria, back pain, increased creatine phosphokinase, bronchitis, flu-like symptoms, pharyngitis, rhinitis, sinusitis.
Drug Interactions
OATP1B1/SLCO1B1 substrates. May increase the levels/effects of ACE inhibitors, antipsychotics (atypical 2nd generation), ciprofloxacin, cyclosporin, drospirenone, duloxetine, hypotension-associated agents, levodopa, lithium, nitropusside, NSAIDs, K-sparing diuretics. Levels/effects may be increased by alfuzosin, aliskiren, barbiturates, brimonidine, canagliflozin, eltrombopag, gemfibrozil, heparin, low molecular wt heparin, nicergoline, pentoxifylline, PDE-5 inhibitors, K salt, prostacyclin analogues, trimethoprim. Decreased effects by amphetamines, methylphenidate, NSAIDs.
ATC Classification
C09CA08 - olmesartan medoxomil ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Esatec 20 FC tab 20 mg
Packing/Price
3 × 10's
Form
Esatec 40 FC tab 40 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in